DXA-Derived Body Composition and Insulin Resistance at Preschool Age in Very-Low-Birth-Weight Preterm Infants: A

Kai-Ti Tseng1,2, Chia-Huei Chen1,2,3, Jui-Hsing Chang1,2

  • 1Department of Pediatrics, MacKay Children's Hospital, Taipei 104217, Taiwan.

Insights

Very-low-birth-weight preterm children show higher insulin resistance at preschool age, even with similar body composition. Overweight status and rapid early weight gain may increase metabolic risks, suggesting a need for early monitoring.

Area of Science:

  • Pediatrics
  • Metabolic Health
  • Body Composition Analysis

Background:

  • Preterm infants often exhibit altered body composition (higher fat, lower lean mass) at term-corrected age.
  • Persistence of these body composition differences into preschool age is not well understood.

Purpose of the Study:

  • To compare body composition and metabolic parameters between very-low-birth-weight (VLBW) preterm children and term-born children at 5-6 years of age.
  • To investigate associations between body composition, weight gain, and insulin resistance in this cohort.

Main Methods:

  • Prospective observational cohort study comparing VLBW preterm children (gestational age < 33 weeks) with term-born controls.
  • Assessment of anthropometric data, body composition (DXA-derived), blood biochemical parameters, and insulin resistance (HOMA-IR index).

Main Results:

  • Despite comparable lean mass index (LMI) and fat mass index (FMI), preterm children had significantly higher insulin levels and HOMA-IR.
  • Overweight/obesity in preterm children was linked to higher fat percentages and HOMA-IR.
  • Weight growth velocity from 2-5 years correlated positively with insulin, HOMA-IR, and fat percentages.

Conclusions:

  • VLBW preterm children exhibit higher insulin resistance at preschool age, irrespective of comparable DXA-derived body composition.
  • Overweight status and rapid early weight gain are potential contributors to increased metabolic risk in this population.
  • Early metabolic monitoring and growth management are crucial for VLBW preterm children.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...